Skip to main content
  • ASCEND trial shows aspirin helps prevent significant vascular events in diabetic adults, but at expense of bleeding whereas omega-3 fatty acid supplements adds no benefit

    A randomized trial of 15,480 adults in the UK who had diabetes but no evidence of cardiovascular disease showed mixed results for aspirin use and no benefit for use of omega-3 fatty acids in preventing serious vascular events at 7.4 years follow-up, according to findings presented Sunday at the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details